title: World Summit of Antivirals--BIT Life Sciences' First Annual Summit. Combating severe viral infections.
authors.affiliation: Cupron Inc, Hameyasdim 44, Kfar Gibton 76910, Israel. gadi@cupron.com
authors.forename: Gadi
authors.initials: G
authors.lastname: Borkow
mesh_terms: D016915:AIDS Vaccines / Q000627:therapeutic use; D000281:Administration, Intranasal; D000282:Administration, Intravaginal; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000906:Antibodies / Q000008:administration & dosage / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D002623:Chemistry Techniques, Analytical; D003300:Copper / Q000627:therapeutic use; D015195:Drug Design; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000276:immunology; D006561:Herpes Simplex / Q000188:drug therapy / Q000821:virology; D018258:Herpesvirus 2, Human / Q000187:drug effects; D006801:Humans; D053125:Influenza A Virus, H5N2 Subtype / Q000276:immunology; D022321:Japanese Encephalitis Vaccines / Q000627:therapeutic use; D009844:Oligosaccharides / Q000627:therapeutic use; D011212:Poxviridae / Q000276:immunology; D012720:Severity of Illness Index; D014613:Vaccines, Attenuated / Q000627:therapeutic use; D019444:Vaccines, DNA / Q000627:therapeutic use; D014765:Viral Vaccines / Q000008:administration & dosage / Q000737:chemistry / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy* / Q000635:transmission / Q000821:virology
chemical_list: D016915:AIDS Vaccines; D000891:Anti-Infective Agents, Local; D000906:Antibodies; D000998:Antiviral Agents; D022321:Japanese Encephalitis Vaccines; D009844:Oligosaccharides; D014613:Vaccines, Attenuated; D019444:Vaccines, DNA; D014765:Viral Vaccines; C496530:cellulose acetate 1,2-benzenedicarboxylate; D003300:Copper; D002482:Cellulose; C030973:cupric oxide